Literature DB >> 24830427

Long-term potentiation of glycinergic synapses triggered by interleukin 1β.

Anda M Chirila1, Travis E Brown1, Rachel A Bishop1, Nicholas W Bellono1, Francesco G Pucci1, Julie A Kauer2.   

Abstract

Long-term potentiation (LTP) is a persistent increase in synaptic strength required for many behavioral adaptations, including learning and memory, visual and somatosensory system functional development, and drug addiction. Recent work has suggested a role for LTP-like phenomena in the processing of nociceptive information in the dorsal horn and in the generation of central sensitization during chronic pain states. Whereas LTP of glutamatergic and GABAergic synapses has been characterized throughout the central nervous system, to our knowledge there have been no reports of LTP at mammalian glycinergic synapses. Glycine receptors (GlyRs) are structurally related to GABAA receptors and have a similar inhibitory role. Here we report that in the superficial dorsal horn of the spinal cord, glycinergic synapses on inhibitory GABAergic neurons exhibit LTP, occurring rapidly after exposure to the inflammatory cytokine interleukin-1 beta. This form of LTP (GlyR LTP) results from an increase in the number and/or change in biophysical properties of postsynaptic glycine receptors. Notably, formalin-induced peripheral inflammation in vivo potentiates glycinergic synapses on dorsal horn neurons, suggesting that GlyR LTP is triggered during inflammatory peripheral injury. Our results define a previously unidentified mechanism that could disinhibit neurons transmitting nociceptive information and may represent a useful therapeutic target for the treatment of pain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24830427      PMCID: PMC4050559          DOI: 10.1073/pnas.1401013111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  71 in total

1.  Rapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammation.

Authors:  Anna K Clark; Fulvio D'Aquisto; Clive Gentry; Fabien Marchand; Stephen B McMahon; Marzia Malcangio
Journal:  J Neurochem       Date:  2006-08-29       Impact factor: 5.372

2.  Regulation of glycine receptor diffusion properties and gephyrin interactions by protein kinase C.

Authors:  Christian G Specht; Nora Grünewald; Olivier Pascual; Nina Rostgaard; Günter Schwarz; Antoine Triller
Journal:  EMBO J       Date:  2011-08-09       Impact factor: 11.598

3.  Effect of protein kinase C activation on the glycine evoked Cl(-) current in spinal cord neurons.

Authors:  F A Albarran; J P Roa; R Navarrete; R Castillo; F Nualart; L G Aguayo
Journal:  Brain Res       Date:  2001-05-25       Impact factor: 3.252

Review 4.  Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control.

Authors:  Hanns Ulrich Zeilhofer; Dietmar Benke; Gonzalo E Yevenes
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-08-15       Impact factor: 13.820

5.  Homeostatic regulation of synaptic GlyR numbers driven by lateral diffusion.

Authors:  Sabine Lévi; Claude Schweizer; Hiroko Bannai; Olivier Pascual; Cécile Charrier; Antoine Triller
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

6.  GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization.

Authors:  Robert J Harvey; Ulrike B Depner; Heinz Wässle; Seifollah Ahmadi; Cornelia Heindl; Heiko Reinold; Trevor G Smart; Kirsten Harvey; Burkhard Schütz; Osama M Abo-Salem; Andreas Zimmer; Pierrick Poisbeau; Hans Welzl; David P Wolfer; Heinrich Betz; Hanns Ulrich Zeilhofer; Ulrike Müller
Journal:  Science       Date:  2004-05-07       Impact factor: 47.728

7.  Low-threshold primary afferent drive onto GABAergic interneurons in the superficial dorsal horn of the mouse.

Authors:  Claire A Daniele; Amy B MacDermott
Journal:  J Neurosci       Date:  2009-01-21       Impact factor: 6.167

8.  Glycine inhibitory dysfunction induces a selectively dynamic, morphine-resistant, and neurokinin 1 receptor- independent mechanical allodynia.

Authors:  Loïs S Miraucourt; Xavier Moisset; Radhouane Dallel; Daniel L Voisin
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

9.  Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation.

Authors:  R-X Zhang; B Liu; A Li; L Wang; K Ren; J-T Qiao; B M Berman; L Lao
Journal:  Neuroscience       Date:  2008-05-07       Impact factor: 3.590

10.  Inhibitory coupling between inhibitory interneurons in the spinal cord dorsal horn.

Authors:  Charalampos Labrakakis; Louis-Etienne Lorenzo; Cyril Bories; Alfredo Ribeiro-da-Silva; Yves De Koninck
Journal:  Mol Pain       Date:  2009-05-12       Impact factor: 3.395

View more
  29 in total

1.  Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord.

Authors:  Sarah Taves; Temugin Berta; Da-Lu Liu; Sophie Gan; Gang Chen; Yong Ho Kim; Thomas Van de Ven; Stefan Laufer; Ru-Rong Ji
Journal:  Brain Behav Immun       Date:  2015-10-19       Impact factor: 7.217

Review 2.  Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain.

Authors:  Gang Chen; Yu-Qiu Zhang; Yawar J Qadri; Charles N Serhan; Ru-Rong Ji
Journal:  Neuron       Date:  2018-12-19       Impact factor: 17.173

Review 3.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Authors:  John R Mantsch; David A Baker; Douglas Funk; Anh D Lê; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-05-15       Impact factor: 7.853

Review 4.  Astrocytes in chronic pain and itch.

Authors:  Ru-Rong Ji; Christopher R Donnelly; Maiken Nedergaard
Journal:  Nat Rev Neurosci       Date:  2019-09-19       Impact factor: 34.870

5.  Glycinergic Inhibitory Plasticity in Binaural Neurons Is Cumulative and Gated by Developmental Changes in Action Potential Backpropagation.

Authors:  Bradley D Winters; Nace L Golding
Journal:  Neuron       Date:  2018-03-22       Impact factor: 17.173

Review 6.  Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.

Authors:  Ru-Rong Ji; Andrea Nackley; Yul Huh; Niccolò Terrando; William Maixner
Journal:  Anesthesiology       Date:  2018-08       Impact factor: 7.892

Review 7.  Spinal α2 -adrenoceptors and neuropathic pain modulation; therapeutic target.

Authors:  Zahra Bahari; Gholam Hossein Meftahi
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

8.  Long-Term Depression Induced by Optogenetically Driven Nociceptive Inputs to Trigeminal Nucleus Caudalis or Headache Triggers.

Authors:  Bruno Pradier; Hye Bin Shin; Duk Soo Kim; Robyn St Laurent; Diane Lipscombe; Julie A Kauer
Journal:  J Neurosci       Date:  2018-07-27       Impact factor: 6.167

9.  Role of interleukin-1 receptor signaling in the behavioral effects of ethanol and benzodiazepines.

Authors:  Yuri A Blednov; Jillian M Benavidez; Mendy Black; Jody Mayfield; R Adron Harris
Journal:  Neuropharmacology       Date:  2015-04-01       Impact factor: 5.250

10.  Functional modulation of glycine receptors by the alkaloid gelsemine.

Authors:  Cesar O Lara; Pablo Murath; Braulio Muñoz; Ana M Marileo; Loreto San Martín; Victoria P San Martín; Carlos F Burgos; Trinidad A Mariqueo; Luis G Aguayo; Jorge Fuentealba; Patricio Godoy; Leonardo Guzman; Gonzalo E Yévenes
Journal:  Br J Pharmacol       Date:  2016-06-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.